PIRS insider filings

PIERIS PHARMACEUTICALS, INC. — 43 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-12-12. Screen PIRS transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for PIRS between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — PIERIS PHARMACEUTICALS, INC.

FiledFormInsiderReported transactionsSource
2024-12-124GERAGHTY JAMES A — DirectorDisposition to issuer (D): 1 @ $0.01EDGAR
2024-12-094KIRITSY CHRISTOPHER P — DirectorGrant/award (A): 500 (derivative) @ $0EDGAR
2024-10-284GERAGHTY JAMES A — DirectorPurchase (P): 1 @ $1EDGAR
2024-08-124ADAR1 Capital Management, LLC — 10% owner
ADAR1 Partners, LP — 10% owner
Purchase (P): 3,000 @ $14.89 · Purchase (P): 2,243 @ $15.88 · Purchase (P): 757 @ $15.88EDGAR
2023-06-234Barbier Ann — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-234Said Maya R. — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-234Richman Michael — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-234Kiener Peter A — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-234Sherman Matthew L — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-234KIRITSY CHRISTOPHER P — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-234GERAGHTY JAMES A — DirectorGrant/award (A): 45,000 (derivative) @ $0EDGAR
2023-05-304KIRITSY CHRISTOPHER P — DirectorPurchase (P): 10,000 @ $0.85EDGAR
2023-02-284Bures Thomas — Chief Financial OfficerGrant/award (A): 249,080 (derivative) @ $0EDGAR
2023-02-284Kaufmann Hitto — Chief Scientific OfficerGrant/award (A): 249,080 (derivative) @ $0EDGAR
2023-02-284Mousa Ahmed — Chief Business OfficerGrant/award (A): 249,080 (derivative) @ $0EDGAR
2023-02-284Olwill Shane — Chief Development OfficerGrant/award (A): 249,080 (derivative) @ $0EDGAR
2023-02-284Yoder Stephen S. — Chief Executive Officer, DirectorGrant/award (A): 634,021 (derivative) @ $0EDGAR
2022-06-244Barbier Ann — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2022-06-244Said Maya R. — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2022-06-244Richman Michael — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2022-06-244Kiener Peter A — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2022-06-244Sherman Matthew L — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2022-06-244KIRITSY CHRISTOPHER P — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2022-06-244GERAGHTY JAMES A — DirectorGrant/award (A): 45,000 (derivative) @ $0EDGAR
2022-05-164Demuth Tim — Chief Medical OfficerPurchase (P): 6,000 @ $1.71EDGAR
2022-02-244Demuth Tim — Chief Medical OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2022-02-244Mousa Ahmed — Chief Business OfficerGrant/award (A): 215,819 (derivative) @ $0EDGAR
2022-02-244Olwill Shane — Chief Development OfficerGrant/award (A): 215,819 (derivative) @ $0EDGAR
2022-02-244Bures Thomas — Chief Financial OfficerGrant/award (A): 215,819 (derivative) @ $0EDGAR
2022-02-244Kaufmann Hitto — SVP, Chief Scientific OfficerGrant/award (A): 215,819 (derivative) @ $0EDGAR
2022-02-244Yoder Stephen S. — Chief Executive Officer, DirectorGrant/award (A): 625,874 (derivative) @ $0EDGAR
2021-09-014Olwill Shane — Chief Development OfficerOption exercise (M): 38,400 @ $1.52 · Sale (S): 9,200 @ $5 · Sale (S): 29,200 @ $5.15 · Option exercise (M): 38,400 (derivative) @ $0EDGAR
2021-08-034Demuth Tim — Chief Medical OfficerGrant/award (A): 360,000 (derivative) @ $0EDGAR
2021-06-294Said Maya R. — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2021-06-294Barbier Ann — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2021-06-294Richman Michael — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2021-06-294Kiener Peter A — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2021-06-294Sherman Matthew L — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2021-06-294KIRITSY CHRISTOPHER P — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2021-06-294GERAGHTY JAMES A — DirectorGrant/award (A): 45,000 (derivative) @ $0EDGAR
2021-03-084Bures Thomas — Vice President, FinanceGrant/award (A): 150,000 (derivative) @ $0EDGAR
2021-03-084Kaufmann Hitto — SVP, Chief Scientific OfficerGrant/award (A): 220,000 (derivative) @ $0EDGAR
2021-03-084Yoder Stephen S. — Chief Executive Officer, DirectorGrant/award (A): 530,000 (derivative) @ $0EDGAR

Recent 8-K events — PIERIS PHARMACEUTICALS, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-198-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-058-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-288-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-048-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-148-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-168-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-208-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-158-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-138-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PIRS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs